JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 166 filers reported holding JUNO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.25 and the average weighting 1.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Biomark Capital Management Co. LLC | 2,168,601 | $40,878,000 | 84.62% |
Crestline Management, LP | 17,348,799 | $327,025,000 | 81.61% |
Omega Fund Management, LLC | 1,229,512 | $23,176,000 | 18.81% |
SIB LLC | 100,000 | $1,885,000 | 1.52% |
BB BIOTECH AG | 1,870,000 | $35,250,000 | 1.31% |
Clearline Capital LP | 116,200 | $2,190,000 | 0.99% |
ARK Investment Management | 141,976 | $2,676,000 | 0.97% |
Clarius Group, LLC | 117,896 | $2,222,000 | 0.94% |
SCOPIA CAPITAL MANAGEMENT LP | 1,778,724 | $33,529,000 | 0.64% |
Baillie Gifford | 11,061,955 | $208,518,000 | 0.34% |